These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3653226)

  • 1. Studies on the metabolism of perhexiline in man.
    Cooper RG; Evans DA; Price AH
    Eur J Clin Pharmacol; 1987; 32(6):569-76. PubMed ID: 3653226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enterohepatic circulation of perhexiline metabolites in the male Wistar rat.
    Cooper RG; Jenkins SA; Evans DA; Price AH
    Xenobiotica; 1988 Apr; 18(4):389-96. PubMed ID: 3400267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic hydroxylation of perhexiline maleate in man.
    Cooper RG; Evans DA; Whibley EJ
    J Med Genet; 1984 Feb; 21(1):27-33. PubMed ID: 6694182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pharmacokinetics of perhexiline administered orally to humans.
    Amoah AG; Gould BJ; Parke DV
    J Chromatogr; 1984 Feb; 305(2):401-9. PubMed ID: 6707167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of perhexiline and its monohydroxy metabolites in biological fluids by gas chromatography-electron-capture detection.
    Cooper RG; Harper G; Price AH; Evans DA; Lockhart D
    J Chromatogr; 1986 Sep; 381(2):305-14. PubMed ID: 3760088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
    Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
    Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the pharmacokinetics of perhexiline maleate in humans.
    Amoah AG; Gould BJ; Parke DV; Lockhart JD
    Xenobiotica; 1986 Jan; 16(1):63-8. PubMed ID: 3946097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia.
    Inglis SC; Herbert MK; Davies BJ; Coller JK; James HM; Horowitz JD; Morris RG; Milne RW; Somogyi AA; Sallustio BC
    Pharmacogenet Genomics; 2007 May; 17(5):305-12. PubMed ID: 17429312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective pharmacokinetics of perhexiline.
    Gould BJ; Amoah AG; Parke DV
    Xenobiotica; 1986 May; 16(5):491-502. PubMed ID: 3739369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
    Morgan MY; Reshef R; Shah RR; Oates NS; Smith RL; Sherlock S
    Gut; 1984 Oct; 25(10):1057-64. PubMed ID: 6479680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy.
    Singlas E; Goujet MA; Simon P
    Eur J Clin Pharmacol; 1978 Nov; 14(3):195-201. PubMed ID: 729614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic hydroxylation of perhexiline in vitro.
    Sørensen LB; Sørensen RN; Miners JO; Somogyi AA; Grgurinovich N; Birkett DJ
    Br J Clin Pharmacol; 2003 Jun; 55(6):635-8. PubMed ID: 12814462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.
    Colburn WA; Vane FM; Bugge CJ; Carter DE; Bressler R; Ehmann CW
    Drug Metab Dispos; 1985; 13(3):327-32. PubMed ID: 2861992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of diazepam in man.
    Eustace PW; Hailey DM; Cox AG; Baird ES
    Br J Anaesth; 1975 Sep; 47(9):983-5. PubMed ID: 1191487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.
    Shah RR; Oates NS; Idle JR; Smith RL; Lockhart JD
    Br Med J (Clin Res Ed); 1982 Jan; 284(6312):295-9. PubMed ID: 6277419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes.
    Davies BJ; Coller JK; Somogyi AA; Milne RW; Sallustio BC
    Drug Metab Dispos; 2007 Jan; 35(1):128-38. PubMed ID: 17050648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti rats.
    Licari G; Somogyi AA; Milne RW; Sallustio BC
    Xenobiotica; 2015 Jan; 45(1):3-9. PubMed ID: 25050791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic assay of perhexiline maleate in plasma.
    Horowitz JD; Morris PM; Drummer OH; Goble AJ; Louis WJ
    J Pharm Sci; 1981 Mar; 70(3):320-2. PubMed ID: 7264901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary excretion of drugs in man.
    Rollins DE; Klaassen CD
    Clin Pharmacokinet; 1979; 4(5):368-79. PubMed ID: 389528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.